ÂÜÀòÂÒÂ×

Ian Eliason is a Partner and Co-founder at Zoic Capital, a life sciences venture fund focused on intellectual property. Since October 2014, Ian has actively sought investment opportunities in early-stage companies. Additionally, Ian serves as an investor and advisor to multiple firms, including HDT Bio, Trio Labs, ChromaTan, Probius, Optina Diagnostics, BioROSA Technologies, InnoVein, and Juno Diagnostics. Ian holds a Bachelor of Science degree in Public Health, Finance, and Communications from the University of Minnesota, obtained between 2013 and 2015.